You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our BCL2L1 Proteins (BCL2L1)

Full name:
BCL2-Like 1 Proteins (BCL2L1)
On are 20 BCL2-Like 1 (BCL2L1) Proteins from 10 different suppliers available. Additionally we are shipping BCL2L1 Antibodies (515) and BCL2L1 Kits (21) and many more products for this protein. A total of 579 BCL2L1 products are currently listed.
Bcl(X)L, bcl-X, bcl-x(l), bcl-xl, BCL-XL/S, Bcl-Xs, Bcl2l, BCL2L1, Bclx, BCLXL, BCLXS, PPP1R52, xR11
list all proteins Gene Name GeneID UniProt
BCL2L1 60480  
BCL2L1 598 Q07817
BCL2L1 24888 P53563

Show all synonyms

BCL2L1 Proteins (BCL2L1) by Origin

Select your origin of interest

Top referenced BCL2L1 Proteins

  1. Human BCL2L1 Primary Antibody for - ABIN2180640 : Terrano, Upreti, Chambers: Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. in Molecular and cellular biology 2010 (PubMed)

  2. Mouse (Murine) BCL2L1 Primary Antibody for - ABIN2007143 : Muchmore, Sattler, Liang, Meadows, Harlan, Yoon, Nettesheim, Chang, Thompson, Wong, Ng, Fesik: X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. in Nature 1996 (PubMed)

More Proteins for BCL2L1 Interaction Partners

Mouse (Murine) BCL2-Like 1 (BCL2L1) interaction partners

  1. MLF1 (show MLF1 Proteins) is negatively regulated by 14-3-3 (show YWHAQ Proteins) via binding to, and blocking, MLF1 (show MLF1 Proteins)'s Bcl-2 (show BCL2 Proteins) homology domain 3 and thereby preventing Bcl-XL from associating with MLF1 (show MLF1 Proteins).

  2. Genetic and pharmacological inhibition of BCL-W (show BCL2L2 Proteins) and BCL-XL causes directed elimination of senescent cells.

  3. Valproic acid sensitized TRAIL-resistant papillary thyroid carcinoma cells to apoptotic cell death through involvement of Nrf2 (show NFE2L2 Proteins) and Bcl-xL.

  4. The influence of chronic ethanol consumption on the expression of the Bdnf (show BDNF Proteins), Bax (show BAX Proteins), Bcl-xL, and CASP3 (show CASP3 Proteins) genes was studied in the brain structures of B6-1473C (C/C) and B6-1473G (G/G) mice that had been obtained on the base of the C57BL/6 strain.

  5. despite its role in Bax (show BAX Proteins) inhibition, Bcl-xL also primes mitochondria to permeabilization and cytochrome c (show CYCS Proteins) release.

  6. These findings indicate that eosinophil survival is largely regulated by betac chain-induced NF-kappaB (show NFKB1 Proteins) activation and subsequent induction of Bcl-x

  7. these data indicate that beta-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA2beta (show PLA2G6 Proteins).

  8. only loss of both Bclx alleles markedly forestalled tumorigenesis, loss of a single Bim (show BCL2L11 Proteins) allele overcame this blockade.

  9. analysis of the role of BCL-XL or MCL-1 (show MCL1 Proteins) in the development and sustained growth of thymic lymphoma elicited by loss of p53 (show TP53 Proteins) reveals that only MCL-1 (show MCL1 Proteins) is critical

  10. cell death is C/EBP homologous protein (CHOP (show DDIT3 Proteins))-dependent, connecting these events to the UPR. Thus plasma cell differentiation proceeds through a Bcl-xL-dependent intermediate.

Human BCL2-Like 1 (BCL2L1) interaction partners

  1. we discovered that deletions involving the PARK2 (show PARK2 Proteins) gene are significantly anti-correlated with focal amplifications of the gene encoding BCL-XL.

  2. The C-terminal tail of BCL-XL forms a membrane-embedded alpha-helix that anchors the protein's globular head to the lipid bilayer membrane, yet retains a significant degree of conformational dynamics.

  3. Bcl-xL overexpression may be closely related to the dynamic of the pathogenesis and development of tongue carcinoma.

  4. Results provide evidence that microRNA 421 induces apoptosis of cervical cancer cells via down-regulation of Bcl-xL.

  5. We conclude that Bcl-x plays a role in regulation of HSC (show FUT1 Proteins) apoptosis and modulation of Bcl-x alternative splicing may become a novel molecular therapy for liver fibrosis.

  6. Intracellular expression of Bcl-xL was significantly greater in CD4 (show CD4 Proteins)+ T-cells, CD8 (show CD8A Proteins)+ T-cells, and NK cells of infants with bronchiolitis compared to controls.

  7. Data indicate the potential of functionalized Apt-carbon nanotubes conjugates for increasing the induction of apoptosis in Mucin-1 (MUC1 (show MUC1 Proteins)) positive tumor cells by suppression of Bcl-xL transcript.

  8. Co-administration of the mTORC1/TORC2 (show CRTC2 Proteins) inhibitor INK128 and the Bcl-2 (show BCL2 Proteins)/Bcl-xL antagonist ABT-737 kills human myeloid leukemia (show BCL11A Proteins) cells through Mcl-1 (show MCL1 Proteins) down-regulation and AKT (show AKT1 Proteins) inactivation.

  9. Genetic and pharmacological inhibition of BCL-W (show BCL2L2 Proteins) and BCL-XL causes directed elimination of senescent cells.

  10. Data suggest that regulation of Bax (show BAX Proteins) stability and transport between cytosol and mitochondria is more tightly regulated by Bcl-xL/BCL2L1 when Bax (show BAX Proteins) has been phosphorylated at Ser184 by AKT1 (show AKT1 Proteins); experiments involved expression in haploid yeast strains.

Pig (Porcine) BCL2-Like 1 (BCL2L1) interaction partners

  1. interleukin-6 (show IL6 Proteins), endothelin ET-1 (show EDN1 Proteins), and apoptotic Bak (show BAK1 Proteins) and Bcl-XL genes have roles in small bowel transplantation, in a swine model of ischemia and reperfusion injury

  2. Bcl-xL was significantly decreased in haploid parthenotes compared with the diploid parthenotes. These results suggest that the haploid state affects apoptosis-related gene expression which results in increased apoptosis

  3. CONCLUSION(S): (1) Apoptosis is involved in follicular atresia; (2) Bcl-2 (show BCL2 Proteins) is induced by warm ischemia; and (3) cryopreservation insult does not alter the apoptotic signals with short tissue preparation time.

  4. Bcl-Xl deamidation and methylation has a role in protein isoaspartate methyltransferase prevention of apoptosis induced by oxidative stress in endothelial cells

  5. Data show that cysteine significantly reduced the expression of pro-inflammatory cytokines, including TNF-alpha (show TNF Proteins), IL-6 (show IL6 Proteins), IL-12p40, IL-1beta (show IL1B Proteins), and resulted in increased expression of the apoptosis initiator caspase-8 (show CASP8 Proteins) and bcl2L1.

Cow (Bovine) BCL2-Like 1 (BCL2L1) interaction partners

  1. amplification and characterization of partial regions of exons 2 and 3 of the bovine BCL2L1 gene

  2. Data show that Bcl-x(L) expression is increased in the pulmonary artery undergoing chronic pulmonary vascular remodeling.

Rabbit BCL2-Like 1 (BCL2L1) interaction partners

  1. This study leads to conclude that BCLXL peak expression at the zygotic genome activation phase may be a requirement for embryo development

  2. In this study evidence is provided that exogenous PGF2alpha differentially modulates luteal expression of BCL2L1 transcripts and protein depending on luteal stage.

Xenopus laevis BCL2-Like 1 (BCL2L1) interaction partners

  1. repression of radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing of its expression and post-translational events that enable the protein to become effective

BCL2L1 Protein Profile

Protein Summary

The protein encoded by this gene belongs to the BCL-2 protein family. BCL-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. The proteins encoded by this gene are located at the outer mitochondrial membrane, and have been shown to regulate outer mitochondrial membrane channel (VDAC) opening. VDAC regulates mitochondrial membrane potential, and thus controls the production of reactive oxygen species and release of cytochrome C by mitochondria, both of which are the potent inducers of cell apoptosis. Two alternatively spliced transcript variants, which encode distinct isoforms, have been reported. The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator.

Alternative names and synonyms associated with BCL2L1

  • BCL2-like 1 (bcl2l1)
  • BCL2-like 1 (BCL2L1)
  • BCL2-like 1 (LOC100224900)
  • transgene insertion 2, Craig B Thompson (Tg(BCL2L1)2Cbt)
  • BCL2-like 1 (Bcl2l1)
  • Bcl2-like 1 (Bcl2l1)
  • Bcl(X)L protein
  • bcl-X protein
  • bcl-x(l) protein
  • bcl-xl protein
  • BCL-XL/S protein
  • Bcl-Xs protein
  • Bcl2l protein
  • BCL2L1 protein
  • Bclx protein
  • BCLXL protein
  • BCLXS protein
  • PPP1R52 protein
  • xR11 protein

Protein level used designations for BCL2-Like 1 Proteins (BCL2L1)

BCL2-like 1 , apoptosis regulator Bcl-X , bcl-2-like protein 1 , protein phosphatase 1, regulatory subunit 52 , B-cell leukemia/lymphoma x , anti-apoptosis regulatory protein , bcl2-L-1 , B cell lymphoma 2 like , B cell lymphoma like X , anti-apoptotic Bcl-xL , BCL2-like protein 1 , Bcl-X , BCLX protein , apoptosis regulator R11

447991 Xenopus (Silurana) tropicalis
458156 Pan troglodytes
100224900 Taeniopygia guttata
60480 Mus musculus
598 Homo sapiens
12048 Mus musculus
24888 Rattus norvegicus
397536 Sus scrofa
403618 Canis lupus familiaris
282152 Bos taurus
100008875 Oryctolagus cuniculus
493701 Felis catus
443061 Ovis aries
373954 Gallus gallus
398251 Xenopus laevis
Selected quality suppliers for BCL2L1 Proteins (BCL2L1)
Did you look for something else?